SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Clarus Therapeutics Holdings, Inc. – ‘10-K’ for 12/31/21 – ‘EXCEL’

On:  Thursday, 3/31/22, at 5:31pm ET   ·   For:  12/31/21   ·   Accession #:  1193125-22-92120   ·   File #:  1-39802

Previous ‘10-K’:  ‘10-K/A’ on 8/16/21 for 12/31/20   ·   Next & Latest:  ‘10-K/A’ on 4/28/22 for 12/31/21   ·   13 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/31/22  Clarus Theraps Holdings, Inc.     10-K       12/31/21   89:9M                                     Donnelley … Solutions/FA

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.27M 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     64K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML     23K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
13: R1          Cover Page                                          HTML    101K 
14: R2          Consolidated Balance Sheets                         HTML    119K 
15: R3          Consolidated Balance Sheets (Parentheticals)        HTML     48K 
16: R4          Consolidated Statements of Operations               HTML    113K 
17: R5          Consolidated Statements of Redeemable Convertible   HTML     80K 
                Preferred Stock and Stockholders' Deficit                        
18: R6          Consolidated Statements of Cash Flows               HTML    118K 
19: R7          Organization and Description of Business            HTML     50K 
                Operations                                                       
20: R8          Summary of Significant Accounting Policies          HTML     88K 
21: R9          Business Combination                                HTML     50K 
22: R10         Fair Value Measurements                             HTML     80K 
23: R11         Inventory                                           HTML     35K 
24: R12         Property and Equipment                              HTML     37K 
25: R13         Accrued Expenses                                    HTML     35K 
26: R14         Debt                                                HTML     65K 
27: R15         Stockholders' Equity (Deficit)                      HTML     67K 
28: R16         Stock Based Compensation                            HTML     74K 
29: R17         Income Taxes                                        HTML     76K 
30: R18         License Agreements                                  HTML     30K 
31: R19         Commitments & Contingencies                         HTML     36K 
32: R20         Net Income (Loss) Per Share                         HTML     72K 
33: R21         Related Party Transactions                          HTML     30K 
34: R22         Subsequent Events                                   HTML     28K 
35: R23         Accounting Policies, by Policy (Policies)           HTML    146K 
36: R24         Summary of Significant Accounting Policies          HTML     50K 
                (Tables)                                                         
37: R25         Business Combination (Tables)                       HTML     47K 
38: R26         Fair Value Measurements (Tables)                    HTML     76K 
39: R27         Inventory (Tables)                                  HTML     37K 
40: R28         Property and Equipment (Tables)                     HTML     36K 
41: R29         Accrued Expenses (Tables)                           HTML     34K 
42: R30         Debt (Tables)                                       HTML     48K 
43: R31         Stockholders' Equity (Deficit) (Tables)             HTML     54K 
44: R32         Stock Based Compensation (Tables)                   HTML     74K 
45: R33         Income Taxes (Tables)                               HTML     71K 
46: R34         Net Income (Loss) Per Share (Tables)                HTML     72K 
47: R35         Organization and Description of Business            HTML     91K 
                Operations (Detail)                                              
48: R36         Summary of Significant Accounting Policies          HTML     34K 
                (Details)                                                        
49: R37         Summary of Significant Accounting Policies          HTML     30K 
                (Details)- Property and Equipment, net                           
50: R38         Summary of Significant Accounting Policies          HTML     31K 
                (Details) - Summary of the deferred revenue                      
                contract liability (Detail)                                      
51: R39         Business Combination - Summary Of Net Proceeds      HTML     32K 
                From The Business Combination (Details)                          
52: R40         Business Combination - Summary Of Common Stock      HTML     42K 
                Issued In Consummation Of Business Combination                   
                (Details)                                                        
53: R41         Business Combination - Summary of Impact of the     HTML     40K 
                transaction on the condensed consolidated                        
                statement of stockholder's equity (Details)                      
54: R42         Business Combination (Details)                      HTML     65K 
55: R43         Fair Value Measurements (Details)                   HTML     80K 
56: R44         Fair Value Measurements (Details) - Schedule of     HTML     45K 
                fair value hierarchy                                             
57: R45         Fair Value Measurements (Details) - Schedule of     HTML     31K 
                changes in the fair value of the Company's warrant               
                liability                                                        
58: R46         Fair Value Measurements - Schedule of simulation    HTML     37K 
                model for the private placement warrants and                     
                public warrants (Details)                                        
59: R47         Inventory (Details) - Schedule of inventory         HTML     37K 
60: R48         Property and Equipment, net (Details)               HTML     27K 
61: R49         Property and Equipment, net (Details) - Schedule    HTML     38K 
                of property and equipment                                        
62: R50         Accrued Expenses (Details) - Schedule of accrued    HTML     33K 
                expenses                                                         
63: R51         Debt (Details)                                      HTML    192K 
64: R52         Debt (Details) - Schedule of carrying value         HTML     33K 
                convertible notes consisted                                      
65: R53         Debt (Details) - Schedule of senior secured notes   HTML     37K 
66: R54         Debt (Details) - Schedule of future principal       HTML     34K 
                payments of the senior secured notes                             
67: R55         Stockholders' Equity (Deficit) (Details)            HTML     87K 
68: R56         Stockholders' Equity (Deficit)- Schedule of         HTML     53K 
                redeemable convertible preferred stock (Detail)                  
69: R57         Stock Based Compensation (Details)                  HTML     79K 
70: R58         Stock-Based Compensation (Details) - Schedule of    HTML     35K 
                weighted-average assumptions                                     
71: R59         Stock Based Compensation (Details) - Schedule of    HTML     35K 
                stock-based compensation expense                                 
72: R60         Stock Based Compensation - Summary of Restricted    HTML     36K 
                Common Stock Activity (Detail)                                   
73: R61         Stock Based Compensation (Details) - Schedule of    HTML     61K 
                stock option activity under the Plans                            
74: R62         Income Taxes (Details)                              HTML     43K 
75: R63         Income Taxes (Details) - Schedule of net deferred   HTML     46K 
                tax assets                                                       
76: R64         Income Taxes (Details) - Schedule of effective      HTML     68K 
                income tax rate                                                  
77: R65         Income Taxes (Details) - Schedule of company's      HTML     31K 
                valuation allowance                                              
78: R66         License Agreements (Details)                        HTML     36K 
79: R67         Commitments & Contingencies (Details)               HTML     44K 
80: R68         Net Income (Loss) Per Share (Details) - Schedule    HTML     78K 
                of basic and diluted earnings (loss) per share                   
                attributable to common stockholders                              
81: R69         Net Income (Loss) Per Share (Details) - Schedule    HTML     29K 
                of basic and diluted earnings (Loss) Per Share                   
                Attributable to Common Stockholders                              
                (Parenthetical)                                                  
82: R70         Net Income (Loss) Per Share (Details) - Schedule    HTML     40K 
                of computation of diluted net loss per share                     
                attributable to common stockholders                              
83: R71         Related Party Transactions (Details)                HTML     31K 
84: R72         Subsequent Events (Details)                         HTML     36K 
87: XML         IDEA XML File -- Filing Summary                      XML    166K 
85: XML         XBRL Instance -- d288074d10k_htm                     XML   1.58M 
86: EXCEL       IDEA Workbook of Financial Reports                  XLSX    111K 
 9: EX-101.CAL  XBRL Calculations -- crxt-20211231_cal               XML    124K 
10: EX-101.DEF  XBRL Definitions -- crxt-20211231_def                XML   1.01M 
11: EX-101.LAB  XBRL Labels -- crxt-20211231_lab                     XML   1.43M 
12: EX-101.PRE  XBRL Presentations -- crxt-20211231_pre              XML   1.20M 
 8: EX-101.SCH  XBRL Schema -- crxt-20211231                         XSD    259K 
88: JSON        XBRL Instance as JSON Data -- MetaLinks              453±   658K 
89: ZIP         XBRL Zipped Folder -- 0001193125-22-092120-xbrl      Zip    430K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/28/22  Clarus Theraps Holdings, Inc.     10-K/A     12/31/21   16:698K                                   Donnelley … Solutions/FA
 4/01/22  Clarus Theraps Holdings, Inc.     POS AM                84:9.7M                                   Donnelley … Solutions/FA
 4/01/22  Clarus Theraps Holdings, Inc.     POS AM                84:9.5M                                   Donnelley … Solutions/FA


10 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/17/21  Clarus Theraps Holdings, Inc.     S-1                   97:12M                                    Donnelley … Solutions/FA
12/07/21  Clarus Theraps Holdings, Inc.     8-K:1,3,8,912/03/21   17:1.1M                                   Donnelley … Solutions/FA
 9/30/21  Clarus Theraps Holdings, Inc.     S-1                  126:13M                                    EdgarAgents LLC/FA
 9/29/21  Clarus Theraps Holdings, Inc.     8-K:1,2,9   9/28/21   12:280K                                   EdgarAgents LLC/FA
 9/15/21  Clarus Theraps Holdings, Inc.     8-K:1,2,3,4 9/09/21   26:2.8M                                   EdgarAgents LLC/FA
 7/23/21  Clarus Theraps Holdings, Inc.     424B3                  1:15M                                    EdgarAgents LLC/FA
 7/19/21  Clarus Theraps Holdings, Inc.     S-4/A       7/16/21   61:21M                                    EdgarAgents LLC/FA
 6/25/21  Clarus Theraps Holdings, Inc.     S-4/A                 72:24M                                    EdgarAgents LLC/FA
 5/03/21  Clarus Theraps Holdings, Inc.     8-K:1,9     4/27/21    9:1.1M                                   EdgarAgents LLC/FA
12/21/20  Clarus Theraps Holdings, Inc.     8-K:1,3,5,812/15/20   11:819K                                   EdgarAgents LLC/FA
Top
Filing Submission 0001193125-22-092120   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 9:46:17.3am ET